Symbol
| HNF4A
| contributors: mct/npt/pgu - updated : 28-02-2019
|
HGNC name
| hepatocyte nuclear factor 4, alpha
|
HGNC id
| 5024
|
corresponding disease(s)
|
MODY1
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
| germinal mutation
|  
|  
|  
|
in diazoxide responsive congenital hyperinsulinism (CHI) | constitutional
| germinal mutation
|  
|  
| loss of function
|
dominant inactivating mutations in children with transient, diazoxide-responsive hyperinsulinism (HI) without clear history of perinatal stress | |
Susceptibility
|
to type 2 diabetes mellitus |
Variant & Polymorphism
SNP
| associated with the risk of type 2 diabetes mellitus |
|
late-onset diabetes mutation, -192C>G, impair the function of the HNF4A P2 |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
digestive | liver | | |
may serve as novel targets for the treatment of liver fibrosis |
| | | |
| in the intestines of adult mice, loss of Hnf-4alpha led to an increased proliferation in crypts and to an increased expression of several genes controlled by the Wnt/beta-catenin system |